1.20
price up icon4.35%   0.05
after-market After Hours: 1.15 -0.05 -4.17%
loading

Rapt Therapeutics Inc Stock (RAPT) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
-
- - - -
Operating Expenses
2.10%
32.52
33.22 33.92 28.36 31.56
Depreciation and Amortization
2.79%
0.314
0.323 0.30 0.30 0.299
Operating Income/Loss
2.10%
-32.52
-33.22 -33.92 -28.36 -31.56
Nonoperating Income/Loss
14.69%
1.997
2.341 2.548 3.084 2.291
Income/Loss From Continuing Operations Before Tax
1.15%
-30.52
-30.88 -31.37 -25.28 -29.27
Income/Loss From Continuing Operations After Tax
1.15%
-30.52
-30.88 -31.37 -25.28 -29.27
Net Income/Loss
1.15%
-30.52
-30.88 -31.37 -25.28 -29.27
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
250.91K%
38.63
0.0154 38.36 38.33 38.28
Diluted Average Shares
250.91K%
38.63
0.0154 38.36 38.33 38.28
Basic Earnings Per Share
2.47%
-0.79
-0.81 -0.82 -0.66 -0.76
Diluted Earnings Per Share
2.47%
-0.79
-0.81 -0.82 -0.66 -0.76
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$78.77
price down icon 0.22%
$313.60
price down icon 1.65%
$33.50
price up icon 0.27%
$19.44
price down icon 3.33%
$96.23
price down icon 3.06%
biotechnology ONC
$262.59
price down icon 1.38%
Cap:     |  Volume (24h):